期刊论文详细信息
BMC Public Health
Visual impairment and multimorbidity in a representative sample of the Spanish population
Josep Maria Haro2  Jose Luis Ayuso-Mateos3  Marta Miret4  Maria Victoria Moneta1  Elvira Lara2  Beatriz Olaya2  Noe Garin2 
[1] Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Dr Antoni Pujades, 42, 08830 Barcelona, Sant Boi de Llobregat, Spain;Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Monforte de Lemos 3–5. Pabellón 11 28029 Madrid, Spain;Instituto de Investigación Sanitaria Princesa (IP), Diego de León, 62, 28006 Madrid, Spain;Department of Psychiatry, Universidad Autónoma de Madrid, Arzobispo Morcillo s/n 28029, Madrid, Spain
关键词: Elderly;    Cognitive functioning;    Mental health;    Low vision;    Visual impairment;    Multimorbidity;    Chronic conditions;    Epidemiology;   
Others  :  1128736
DOI  :  10.1186/1471-2458-14-815
 received in 2014-04-02, accepted in 2014-06-26,  发布年份 2014
PDF
【 摘 要 】

Background

In the context of population aging, visual impairment has emerged as a growing concern in public health. However, there is a need for further research into the relationship between visual impairment and chronic medical conditions in the elderly. The aim of our study was to examine the relationship between visual impairment and three main types of co-morbidity: chronic physical conditions (both at an independent and additive level), mental health and cognitive functioning.

Methods

Data were collected from the COURAGE in Europe project, a cross-sectional study. A total of 4,583 participants from Spain were included. Diagnosis of chronic medical conditions included self-reported medical diagnosis and symptomatic algorithms. Depression and anxiety were assessed using CIDI algorithms. Visual assessment included objective distance/near visual acuity and subjective visual performance. Descriptive analyses included the whole sample (n = 4,583). Statistical analyses included participants aged over 50 years (n = 3,625; mean age = 66.45 years) since they have a significant prevalence of chronic conditions and visual impairment. Crude and adjusted binary logistic regressions were performed to identify independent associations between visual impairment and chronic medical conditions, physical multimorbidity and mental conditions. Covariates included age, gender, marital status, education level, employment status and urbanicity.

Results

The number of chronic physical conditions was found to be associated with poorer results in both distance and near visual acuity [OR 1.75 (CI 1.38-2.23); OR 1.69 (CI 1.27-2.24)]. At an independent level, arthritis, stroke and diabetes were associated with poorer distance visual acuity results after adjusting for covariates [OR 1.79 (CI 1.46-2.21); OR 1.59 (CI 1.05-2.42); OR 1.27 (1.01-1.60)]. Only stroke was associated with near visual impairment [OR 3.01 (CI 1.86-4.87)]. With regard to mental health, poor subjective visual acuity was associated with depression [OR 1.61 (CI 1.14-2.27); OR 1.48 (CI 1.03-2.13)]. Both objective and subjective poor distance and near visual acuity were associated with worse cognitive functioning.

Conclusions

Arthritis, stroke and the co-occurrence of various chronic physical diseases are associated with higher prevalence of visual impairment. Visual impairment is associated with higher prevalence of depression and poorer cognitive function results. There is a need to implement patient-centered care involving special visual assessment in these cases.

【 授权许可】

   
2014 Garin et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20151107151348319.pdf 458KB PDF download
【 参考文献 】
  • [1]Lee DJ, Gómez-Marín O, Lam BL, Zheng DD, Caban A: Visual impairment and morbidity in community-residing adults: the national health interview survey 1986–1996. Ophthalmic Epidemiol 2005, 12(1):13-17.
  • [2]Li Y, Crews JE, Elam-Evans LD, Fan AZ, Zhang X, Elliott AF, Balluz L: Visual impairment and health-related quality of life among elderly adults with age-related eye diseases. Qual Life Res 2011, 20(6):845-852.
  • [3]Finger RP, Fenwick E, Marella M, Dirani M, Holz FG, Chiang PP-C, Lamoureux EL: The impact of vision impairment on vision-specific quality of life in Germany. Invest Ophthalmol Vis Sci 2011, 52(6):3613-3619.
  • [4]Chia E-M, Mitchell P, Rochtchina E, Foran S, Wang JJ: Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br J Ophthalmol 2003, 87(4):392-395.
  • [5]Du Toit R, Palagyi A, Ramke J, Brian G, Lamoureux EL: The impact of reduced distance and near vision on the quality of life of adults in Timor-Leste. Ophthalmology 2010, 117(12):2308-2314.
  • [6]Lopez D, McCaul KA, Hankey GJ, Norman PE, Almeida OP, Dobson AJ, Byles JE, Yeap BB, Flicker L: Falls, injuries from falls, health related quality of life and mortality in older adults with vision and hearing impairment–is there a gender difference? Maturitas 2011, 69(4):359-364.
  • [7]Grue EV, Ranhoff AH, Noro A, Finne-Soveri H, Jensdóttir AB, Ljunggren G, Bucht G, Björnson LJ, Jonsén E, Schroll M, Jónsson PV: Vision and hearing impairments and their associations with falling and loss of instrumental activities in daily living in acute hospitalized older persons in five Nordic hospitals. Scand J Caring Sci 2009, 23(4):635-643.
  • [8]Zheng DD, Christ SL, Lam BL, Arheart KL, Galor A, Lee DJ: Increased mortality risk among the visually impaired: the roles of mental well-being and preventive care practices. Invest Ophthalmol Vis Sci 2012, 53(6):2685-2692.
  • [9]World Health Organization: Global Initiative for the Elimination of Avoidable Blindness. Action Plan 2006–2011. France: WHO Library Cataloguing-in-Publication Data; 2007:90. [http://www.who.int/blindness/Vision2020_report.pdf webcite
  • [10]World Health Organization: International Classification of Functioning, Disability and Health: ICF. Geneva: WHO Library Cataloguing-in-Publication Data; 2001:299.
  • [11]Finger RP, Bertram B, Wolfram C, Holz FG: Blindness and visual impairment in Germany: a slight fall in prevalence. Dtsch Arztebl Int 2012, 109(27–28):484-489.
  • [12]Sainz-Gómez C, Fernández-Robredo P, Salinas-Alamán A, Montañés JM, Escudero Berasategui JM, Guillén-Grima F, Ruiz-Moreno JM, García-Layana A: Prevalence and causes of bilateral blindness and visual impairment among institutionalized elderly people in Pamplona, Spain. Eur J Ophthalmol 2010, 20(2):442-450.
  • [13]World Health Organization: Executive board: draft action plan for the prevention of avoidable blindness and visual impairment 2014–2019. Universal eye health: a global action plan 2014–2019. 2013. http://apps.who.int/gb/ebwha/pdf_files/EB132/B132_9-en.pdf webcite
  • [14]Lee DJ, Lam BL, Gómez-Marín O, Zheng DD, Caban AJ: Concurrent hearing and visual impairment and morbidity in community-residing adults: the National Health Interview Survey, 1986 to 1996. J Aging Health 2005, 17(5):531-546.
  • [15]United Nations. Department of Economic and Social Affairs. Population Division: Population ageing and development 2012. 2012. http://www.un.org/esa/population/publications/2012WorldPopAgeingDev_Chart/2012PopAgeingandDev_WallChart.pdf webcite
  • [16]Olusanya B, Onoja G, Ibraheem W, Bekibele C: Profile of patients presenting at a low vision clinic in a developing country. BMC Ophthalmol 2012, 12:31. doi:10.1186/1471-2415-12-31
  • [17]Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, Poncel-Falcó A, Sicras-Mainar A, Alcalá-Nalvaiz JT: Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One 2012, 7(2):e32190. doi:10.1371/journal.pone.0032190
  • [18]Uijen AA, van de Lisdonk EH: Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract 2008, 14(Suppl 1):28-32.
  • [19]Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L: Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011, 10(4):430-439.
  • [20]Tarr JM, Kaul K, Wolanska K, Kohner EM, Chibber R: Retinopathy in diabetes. Adv Exp Med Biol 2012, 771:88-106.
  • [21]Lotery A, Xu X, Zlatava G, Loftus J: Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study. Br J Ophthalmol 2007, 91(10):1303-1307.
  • [22]Hayman KJ, Kerse NM, La Grow SJ, Wouldes T, Robertson MC, Campbell AJ: Depression in older people: visual impairment and subjective ratings of health. Optom Vis Sci 2007, 84(11):1024-1030.
  • [23]Donoyama N, Takeda F: Mental health and related factors among massage practitioners with visual impairment. Ind Health 2007, 45(2):191-198.
  • [24]Evans JR, Fletcher AE, Wormald RPL: Depression and anxiety in visually impaired older people. Ophthalmology 2007, 114(2):283-288.
  • [25]Lamoureux EL, Fenwick E, Moore K, Klaic M, Borschmann K, Hill K: Impact of the severity of distance and near-vision impairment on depression and vision-specific quality of life in older people living in residential care. Invest Ophthalmol Vis Sci 2009, 50(9):4103-4109.
  • [26]Lam BL, Christ SL, Lee DJ, Zheng DD, Arheart KL: Reported visual impairment and risk of suicide: the 1986–1996 national health interview surveys. Arch Ophthalmol 2008, 126(7):975-980.
  • [27]Chang LYL, Lowe J, Ardiles A, Lim J, Grey AC, Robertson K, Danesh-Meyer H, Palacios AG, Acosta ML: Alzheimer’s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers. Alzheimers Dement 2014, 10(2):251-261.
  • [28]Elyashiv SM, Shabtai EL, Belkin M: Correlation between visual acuity and cognitive functions. Br J Ophthalmol 2014, 98(1):129-132.
  • [29]Sloan FA, Ostermann J, Brown DS, Lee PP: Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. Am J Ophthalmol 2005, 140(4):618-627.
  • [30]Elliott AF, McGwin G, Owsley C: Vision impairment among older adults residing in assisted living. J Aging Health 2013, 25(2):364-378.
  • [31]Ong SY, Cheung CY, Li X, Lamoureux EL, Ikram MK, Ding J, Cheng CY, Haaland BA, Saw SM, Venketasubramanian N, Chen CP, Wong TY: Visual impairment, age-related eye diseases, and cognitive function: the Singapore Malay Eye study. Arch Ophthalmol 2012, 130(7):895-900.
  • [32]Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Jacob KS, Jotheeswaran AT, Liu Z, Rodriguez JJ, Salas A, Sosa AL, Williams JD: The association between common physical impairments and dementia in low and middle income countries, and, among people with dementia, their association with cognitive function and disability. A 10/66 Dementia Research Group population-based study. Int J Geriatr Psychiatry 2011, 26(5):511-519.
  • [33]Clemons TE, Rankin MW, McBee WL: Cognitive impairment in the Age-related Eye disease study: AREDS report no. 16. Arch Ophthalmol 2006, 124(4):537-543.
  • [34]Leonardi M, Chatterji S, Koskinen S, Ayuso-Mateos JL, Haro JM, Frisoni G, Frattura L, Martinuzzi A, Tobiasz-Adamczyk B, Gmurek M, Serrano R, Finocchiaro C, on behalf of COURAGE in Europe Project’s Consortium: Determinants of health and disability in ageing population: the COURAGE in Europe project (Collaborative Research on Ageing in Europe). Clin Psychol Psychother 2013. doi:10.1002/cpp.1856
  • [35]World Health Organization: WHO Process of Translation and Adaptation of Instruments. World Health Organization; Available from: http://www.who.int/substance_abuse/research_tools/translation/en/ webcite
  • [36]Ustun TB, Chatterji S, Mechbal A, Murray CJL, WHS collaborating groups: Chapter X: Quality Assurance in Surveys: Standards, Guidelines and Procedures. In Household Sample Surveys in Developing and Transition Countries. Edited by United Nations. New York: United Nations Publications; 2005:199-230. [http://unstats.un.org/unsd/hhsurveys/pdf/Household_surveys.pdf webcite]
  • [37]Hinton R, Moody RL, Davis AW, Thomas SF: Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician 2002, 65(5):841-848.
  • [38]Global initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2013. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf webcite
  • [39]Global Initiative for Asthma: Global strategy for asthma management and prevention. 2012. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014_Aug12.pdf webcite
  • [40]National Collaboratoring Centre for Chronic Conditions: NICE Clinical Guideline 68: Stroke, Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). NHS NICE; 2008. http://www.nice.org.uk/guidance/cg68/resources/guidance-stroke-pdf webcite
  • [41]American Optometric Association: Optometric clinical practice guideline: care of the adult patient with cataract. 2004. http://www.aoa.org/documents/CPG-8.pdf webcite
  • [42]Alves L, Cesar JA, Horta BL: Prevalence of angina pectoris in Pelotas, South of Brazil. Arq Bras Cardiol 2010, 95(2):179-185.
  • [43]Kowal P, Chatterji S, Naidoo N, Biritwum R, Fan W, Lopez Ridaura R, Maximova T, Arokiasamy P, Phaswana-Mafuya N, Williams S, Snodgrass JJ, Minicuci N, D’Este C, Peltzer K, Boerma JT, SAGE Collaborators: Data resource profile: the World Health Organization Study on global AGEing and adult health (SAGE). Int J Epidemiol 2012, 41(6):1639-1649.
  • [44]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
  • [45]Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989, 39(9):1159-1165.
  • [46]Psychological Corporation: The WAIS III - WMS III updated technical manual. San Antonio, TX: Psychological Corporation; 2002.
  • [47]Perales J, Martin S, Ayuso-Mateos JL, Chatterji S, Garin N, Koskinen S, Leonardi M, Miret M, Moneta V, Olaya B, Tobiasz-Adamczyk B, Haro JM: Factors associated with active aging in Finland, Poland, and Spain. Int Psychogeriatr 2014, 1-13. http://dx.doi.org/10.1017/S1041610214000520 webcite
  • [48]He W, Muenchrath M, Kowal P: A cross-country study of health and well-being of the older populations in SAGE countries, 2007–2010. 2012. Available from: [http://www.census.gov/prod/2012pubs/p95-12-01.pdf webcite]
  • [49]Keeffe JE, Lovie-Kitchin JE, Maclean H, Taylor HR: A simplified screening test for identifying people with low vision in developing countries. Bull World Health Organ 1996, 74(5):525-532.
  • [50]Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174.
  • [51]Rahi JS, Cumberland PM, Peckham CS: Visual impairment and vision-related quality of life in working-age adults: findings in the 1958 British birth cohort. Ophthalmology 2009, 116(2):270-274.
  • [52]Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K: A standard procedure for creating a frailty index. BMC Geriat 2008. doi:10.1186/1471-2318-8-24
  • [53]Richter GM, Torres M, Choudhury F, Azen SP, Varma R: Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino Eye Study. Ophthalmology 2012, 119(3):547-554.
  • [54]Falsarella GR, Coimbra IB, Barcelos CC, Costallat LT, Carvalho OM, Coimbra AM: Prevalence and factors associated with rheumatic diseases and chronic joint symptoms in the elderly. Geriatr Gerontol Int 2013, 13(4):1043-1050.
  • [55]Stitt AW, Lois N, Medina RJ, Adamson P, Curtis TM: Advances in our understanding of diabetic retinopathy. Clin Sci (Lond) 2013, 125(1):1-17.
  • [56]Sen K, Misra A, Kumar A, Pandey RM: Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract 2002, 56(1):1-11.
  • [57]Rowe F, Brand D, Jackson CA, Price A, Walker L, Harrison S, Eccleston C, Scott C, Akerman N, Dodridge C, Howard C, Shipman T, Sperring U, MacDiarmid S, Freeman C: Visual impairment following stroke: do stroke patients require vision assessment? Age Ageing 2009, 38(2):188-193.
  • [58]Lotery A: Correctable visual impairment in stroke rehabilitation patients. Age Ageing 2000, 29(3):221-222.
  • [59]Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R: Extra-articular manifestations in rheumatoid arthritis. Maedica 2010, 5(4):286-291.
  • [60]Ozdal PC, Vianna RNG, Deschênes J: Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ocul Immunol Inflamm 2005, 13(1):33-38.
  • [61]Marmor MF, Kellner U, Lai TYY, Lyons JS, Mieler WF: Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011, 118(2):415-422.
  • [62]Razeghinejad MR, Katz LJ: Steroid-induced iatrogenic glaucoma. Ophthalmic Res 2012, 47(2):66-80.
  • [63]James ER: The etiology of steroid cataract. J Ocul Pharmacol Ther 2007, 23(5):403-420.
  • [64]Shah SP, Desai CK, Desai MK, Dikshit RK: Steroid-induced central serous retinopathy. Indian J Pharmacol 2011, 43(5):607-608.
  • [65]Kirchberger I, Meisinger C, Heier M, Zimmermann A-K, Thorand B, Autenrieth CS, Peters A, Ladwig KH, Döring A: Patterns of multimorbidity in the aged population. Results from the KORA-Age study. PLoS One 2012, 7(1):e30556.
  • [66]Nyman SR, Gosney MA, Victor CR: Psychosocial impact of visual impairment in working-age adults. Br J Ophthalmol 2010, 94(11):1427-1431.
  • [67]Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D, Rapaport MH, Kaplan RM, Brown SI: Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001, 108(10):1893-1900. discussion 1900–1
  • [68]Horowitz A, Reinhardt JP, Kennedy GJ: Major and subthreshold depression among older adults seeking vision rehabilitation services. Am J Geriatr Psychiatry 2005, 13(3):180-187.
  • [69]Margolis MK, Coyne K, Kennedy-Martin T, Baker T, Schein O, Revicki DA: Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review. Pharmacoeconomics 2002, 20(12):791-812.
  • [70]Massof RW, Rubin GS: Visual function assessment questionnaires. Surv Ophthalmol 2001, 45(6):531-548.
  • [71]Alma MA, van der Mei SF, Melis-Dankers BJM, van Tilburg TG, Groothoff JW, Suurmeijer TPBM: Participation of the elderly after vision loss. Disabil Rehabil 2011, 33(1):63-72.
  • [72]Heine C, Browning CJ: Communication and psychosocial consequences of sensory loss in older adults: overview and rehabilitation directions. Disabil Rehabil 2002, 24(15):763-773.
  • [73]Steinman BA, Allen SM: Self-reported vision impairment and its contribution to disability among older adults. J Aging Health 2012, 24(2):307-322.
  • [74]Jampel HD, Frick KD, Janz NK, Wren PA, Musch DC, Rimal R, Lichter PR, CIGTS Study Group: Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol 2007, 144(2):238-244.
  • [75]Lee PP, Whitcup SM, Hays RD, Spritzer K, Javitt J: The relationship between visual acuity and functioning and well-being among diabetics. Qual Life Res 1995, 4(4):319-323.
  • [76]The Royal College of Ophthalmologists: Cataract Surgery Guidelines. 2010.
  • [77]Cumurcu T, Cumurcu BE, Celikel FC, Etikan I: Depression and anxiety in patients with pseudoexfoliative glaucoma. Gen Hosp Psychiatry 2006, 28(6):509-515.
  • [78]Jangra D, Ganesh A, Thackray R, Austin L, Ulster A, Sutherland J, Levin AV: Psychosocial adjustment to visual loss in patients with retinitis pigmentosa. Ophthalmic Genet 2007, 28(1):25-30.
  • [79]Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE, Mills RP, CIGTS Study Group: The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001, 108(11):1954-1965.
  • [80]Mabuchi F, Yoshimura K, Kashiwagi K, Shioe K, Yamagata Z, Kanba S, Iijima H, Tsukahara S: High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma 2008, 17(7):552-557.
  • [81]Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, Lepine JP, Mazzi F, Reneses B, Vilagut G, Sampson NA, Kessler RC: Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res 2006, 15(4):167-180.
  • [82]Gussekloo J, de Craen AJM, Oduber C, van Boxtel MPJ, Westendorp RGJ: Sensory impairment and cognitive functioning in oldest-old subjects: the Leiden 85+ Study. Am J Geriatr Psychiatry 2005, 13(9):781-786.
  • [83]Wood J, Chaparro A, Anstey K, Lacherez P, Chidgey A, Eisemann J, Gaynor A, La P: Simulated visual impairment leads to cognitive slowing in older adults. Optom Vis Sci 2010, 87(12):1037-1043.
  • [84]Wood JM, Chaparro A, Anstey KJ, Hsing YE, Johnsson AK, Morse AL, Wainwright SE: Impact of simulated visual impairment on the cognitive test performance of young adults. Br J Psychol 2009, 100(Pt 3):593-602.
  • [85]Kirby E, Bandelow S, Hogervorst E: Visual impairment in Alzheimer’s disease: a critical review. J Alzheimers Dis 2010, 21(1):15-34.
  • [86]Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD: Visual dysfunction in Parkinson disease without dementia. Neurology 2005, 65(12):1907-1913.
  • [87]Archibald NK, Clarke MP, Mosimann UP, Burn DJ: Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 2011, 26(13):2387-2395.
  • [88]Iseri PK, Altinaş O, Tokay T, Yüksel N: Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006, 26(1):18-24.
  • [89]Whitson HE, Cousins SW, Burchett BM, Hybels CF, Pieper CF, Cohen HJ: The combined effect of visual impairment and cognitive impairment on disability in older people. J Am Geriatr Soc 2007, 55(6):885-891.
  • [90]Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ: Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients’ self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996, 49(12):1407-1417.
  • [91]Violán C, Foguet-Boreu Q, Hermosilla-Pérez E, Valderas JM, Bolíbar B, Fàbregas-Escurriola M, Brugulat-Guiteras P, Muñoz-Pérez MÁ: Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity. BMC Public Health 2013, 13:251. doi:10.1186/1471-2458-13-251
  • [92]Papas EB, Schultz BL: Repeatability and comparison of visual analogue and numerical rating scales in the assessment of visual quality. Ophthalmic Physiol Opt 1997, 17(6):492-498.
  • [93]Jefferis JM, Collerton J, Taylor J-P, Jagger C, Kingston A, Davies K, Kirkwood T, Clarke MP: The impact of visual impairment on mini-mental state examination scores in the Newcastle 85+ study. Age Ageing 2012, 41(4):565-568.
  • [94]Bertone A, Bettinelli L, Faubert J: The impact of blurred vision on cognitive assessment. J Clin Exp Neuropsychol 2007, 29(5):467-476.
  文献评价指标  
  下载次数:1次 浏览次数:11次